what to do with all of these lung nodules? · 2018. 4. 19. · what to do with all of these lung...
TRANSCRIPT
-
Can Respir J Vol 21 No 3 May/June 2014e52
What to do with all of these lung nodules?Dmitry Rozenberg MD1,2, Shane Shapera MD1,2
1Division of Respiratory Medicine; 2Department of Medicine, University of Toronto, Toronto General Hospital, Toronto, OntarioCorrespondence: Dr Dmitry Rozenberg, 9N 971 – 585 University Avenue, Toronto, Ontario M5G 2N2.
Telephone 416-340-4800, fax 416-340-3254, e-mail [email protected]
Learning objectives• To recognize that Caplan syndrome is a rare pulmonary
manifestation of rheumatoid arthritis (RA) found in patientswithoccupationaldustexposure.
• To be aware of the differential diagnosis andmanagement ofcavitarypulmonarynodulesinCaplansyndrome.
CAN MEDS Competency: Medical Expert
Pretest• WhatistheclassicclinicalandradiologicalpresentationofCaplan
syndrome?• Whatisthedifferentialdiagnosisofcavitarypulmonarynodules
inRA?• HowdoyoutreatCaplansyndrome?
CASE PrESENtAtioNA71-year-oldmanwasreferredtotheauthors’facilitywithafive-yearhistoryofmultiple,bilateralcavitarylungnodules.Hewasasymptom-aticfromarespiratorystandpoint,withonlymilddyspneaonexertionoverthepast sixmonths,withnoweight loss,coughorhemoptysis.Thepatientdescribeda10-yearhistoryofpolyarthritisconsistentwithhisknowndiagnosisofseropositiverheumatoidarthritis(RA).HisRAwaspreviouslywellcontrolledwithmethotrexateandleflunomideforseveralyears.Fouryearsbeforepresentingtotheauthors’centre,hismedicationswerechangedtoazathioprineandprednisone,giventheconcernofmultiplelungnodules(Figure1A).Healsohadischemiccardiomyopathy,atrial fibrillation, type2diabetesandgastroesopha-gealrefluxdisease.
Hewasaretiredconstructionworkerwhohadsignificantexposuretorockdustasaresultofrockdrillingfor10yearsandrockminingingraphiteminesinthelatterpartofhiscareer.Hehadnoasbestosorsandblasting exposure.Hewas an ex-smoker (30 pack-year history)withnoalcoholorrecreationaldruguse.Hedescribednotuberculosisexposures.Hisfamilyhistorywasnoncontributory.
Onexamination,thepatientappearedcomfortableandinnores-piratorydistress.Hiscardiorespiratoryexaminationwasunremarkableaside from an oxygen saturation of 92%on room air.Hehad hand
changesconsistentwithadiagnosisofRAwithnodigitalclubbing.Hehadnosubcutaneousnodules,rashesorjointswelling.
Hispulmonaryfunctiontestsdemonstratedamixedpatternwithmildrestriction(totallungcapacity5.0L[70%predicted])andpost-bronchodilatorobstruction (forced expiratoryvolume in1 s [FEV1]/forcedvitalcapacity[FVC]ratio0.67;FEV11.46L[45%ofpredicted])withamoderatereductioninhisdiffusingcapacityforcarbonmonox-ide(DLCO)(47%).Hisvitalcapacity(VC)was2.2L(49%)andhisresidualvolume2.8L (110%).His rheumatoid factor (>650kIU/L)andanticitrullinatedproteinantibody(500mg/L)werestronglyposi-tive;antinuclearantibody,extranuclearantigenpanelandantinuclearcytoplasmicantibodieswerenegative;anderythrocyte sedimentationrate(73mm/h)andC-reactiveprotein(77mg/L)weremoderatelyele-vated.Hisechocardiogramhadshownaleftventricularejectionfractionof40%,withnoevidenceofpulmonaryhypertension.
Chestimagingdemonstratedstablecalcifiedmediastinalandhilarlymphadenopathywithnumerousparenchymalnodulesandcavities,whichhadwaxedandwanedoverthepast fiveyears(Figures1Ato1C).Culturesfromaspontaneoussputumsample(cultureandsensi-tivity, acid-fast bacilli and fungal) were negative sixmonths beforepresentationattheauthors’centre.Subsequently,bronchoscopydem-onstratednormalanatomy,cytologyandasecondsetofnegativecul-tures(cultureandsensitivity,acid-fastbacilliandfungal).Aleft-sidedvideo-assistedthoracicsurgicalbiopsyrevealedmultiplenoduleswithnecrosis surroundedbydust,withareasof surrounding inflammationandfibroblasticresponse(Figures2Aand2B).AdiagnosisofCaplansyndromewasmade.
HisreferringphysicianswereadvisedtocontinuewiththecurrentextrapulmonaryRAmanagement.Tiotropiumwasstartedforhiscon-comitant airflow obstruction with improvement in his pulmonaryfunctiontests(totallungcapacity5.4L[78%ofpredicted];FEV1/FVCratio0.90;FEV12.2L[70%]).HisVCwas2.5L(56%),residualvol-ume2.9L(116%)andDLCO(58%).Thenodulesremainunchangedoveroneyearoffollow-up.
DiSCuSSioNWithaprevalenceofapproximately1%inCanada(1),RAhasmanypulmonary manifestations: necrobiotic nodules, interstitial disease,pleuralabnormalities,bronchiolitisobliterans,vasculitis,drug-inducedlungdisease,upperairwaydisease,organizingpneumoniaandCaplansyndrome(2,3).
clinico-pathologic conferences
©2014PulsusGroupInc.Allrightsreserved
D rozenberg, S Shapera. What to do with all of these lung nodules? Can respir J 2014;21(3):e52-e54.
Caplansyndromeisarareentitythatisspecifictorheumatoidarthritisandpresents with multiple, well-defined necrotic nodules in patients withoccupationaldustexposure.ThepresentreportdescribesacaseofCaplansyndromeinvolvinga71-year-oldmanwithaknowndiagnosisofseroposi-tiverheumatoidarthritiswhopresentedtotheauthors’centrewithafive-yearhistoryofmultiple,bilateralcavitarylungnoduleswithmilddyspneaon exertion. He was an ex-smoker (30 pack-years) and had previouslyworkedwithsilica.Thecasehighlightstheclinical,radiologicalandpatho-logicalfeaturesofthissyndromeandoutlinestheimportanceofconsider-ing a broad differential in the management of pulmonary nodules,especiallyinpatientswithrheumatoidarthritis.
Key Words: Lung diseases; Nodules; Pneumoconiosis; Rheumatoid arthritis
Que faire de tous ces nodules pulmonaires?
LesyndromedeCaplanestuneentitérarepropreàlapolyarthriterhuma-toïde qui semanifeste par demultiples nodules nécrotiques bien définischezdespatientsqui,àcausedeleurtravail,sontexposésàlapoussière.Leprésentrapportdécritlecasd’unhommede71ansatteintdusyndromedeCaplanayantundiagnosticconnudepolyarthriterhumatoïdeséropositive.Ilaconsultéaucentredesauteursetprésentaitdemultiplesnodulespul-monairescavitairesbilatérauxaccompagnésd’unelégèredyspnéeàl’effort.Ancienfumeur(30paquets-années),ilavaitdéjàtravailléavecdelasilice.Le cas fait ressortir les caractéristiques cliniques, radiologiques etpathologiquesdecesyndromeainsiquel’importanced’envisagerunvastediagnostic différentiel dans la prise en charge des nodules pulmonaires,surtoutchezlespatientsatteintsdepolyarthriterhumatoïde.
-
What to do with all of these lung nodules?
Can Respir J Vol 21 No 3 May/June 2014 e53
Theprevalenceofnodules inRA isdifficult toestimate. In twooldercase seriesofRApatientswith253and702patients screenedusingchestx-ray,nonoduleswereidentified(4,5).However,onestudydemonstratedpulmonarynodulestobequitecommon,foundin13of40(32%)patientswhounderwentbiopsyforsuspectedlunginvolve-ment (6).Multiple cavitarypulmonarynodules canhavemalignantandbenignetiologies,asoutlinedinTable1.
Inthepresentcase,malignancyandinfection(includingmycobac-terium)wasbelievedtobeunlikelygiventheindolentcourse,normal
sputum cultures, negative bronchoscopy and video-assisted thoracicsurgicalbiopsy.AdiagnosisofCaplan syndromewasmadebasedonthe diagnostic criteria of multiple, well-defined pulmonary nodulesandinorganicdustexposureinapatientwithRA(7).Anopen-lungbiopsywasnot absolutelynecessary, butwashelpful to confirm thisrareentityandexcludealternativediagnoses.HistopathologycanbeusefulinpatientswithoutadiagnosisofRAbecausethenodulescanprecedetheonsetofRAsymptoms.
Caplan (8) originally described this entity in 1953, havingobservedanincreasedprevalenceofpulmonarymanifestationsincoalminerswithRAwhowereexposedtomineralcoalorsilicadust.Heobservedwell-defined roundedopacities0.5cmto5cm in size thatwerebilateralandpredominantlyperipheralonchestx-ray,apatterndifferentfromprogressivemassivefibrosis(PMF),associatedwithcoalworker’s pneumoconiosis.Althoughmost cases ofCaplan syndromehave been reported in coal workers, some have been in patientsexposedtoasbestosorfreesilica(9,10),asinourcase.
The majority of the literature regarding Caplan syndrome waspublished before the advent of chest computed tomography (CT),with relianceentirelyonchestx-rays.Althougha fewcase reportshave described using chest CT, it has not been helpful in distin-guishing Caplan syndrome from simple silicotic nodules (11,12).However,CT imaging can be useful in recognizing other forms ofRA-associatedlungdisease.Typically,radiologicalfindingsofCaplansyndromeincludebenign-appearingnodulesthatcancoalesce,cavi-tateorcalcifyintheperipheryofthelung(7).Althoughuncommon,pulmonarycomplicationscanincludepneumothorax,pleuraleffusions,hemoptysisand,mostimportantly,anincreasedprevalenceoftubercu-losiscomparedwithotherpneumoconioses(5).AmorecomprehensiveoverviewoftheclinicalandradiologicalpresentationscanbefoundinareviewarticlebySchreiberetal(7).
Figure 1) A Computed tomography scan (coronal view) demonstrating bilateral nodules in the upper lung zones (blue arrows) and calcified hilar lymphaden-opathy (white arrows) five years before presentation. B Computed tomography scan (axial images) illustrating calcified lymph nodes (white arrows) five years before presentation. C Computed tomography scan (axial view) illustrating cavitation of the pulmonary nodules (blue arrows)
Figure 2) A High magnification (×100) view of a necrotic nodule (star marks area of necrosis) containing abundant dust particles (arrow). Hematoxylin and eosin stain. B High magnification (×100) view of mixed dust nodule, with abundant silicotic and anthracotic dust particles (arrows), admixed with lymphohis-tiocytic cells and fibrosis (star). Hematoxylin and eosin stain
Table 1Differential for multiple cavitary pulmonary nodulesetiology example Neoplasm Bronchogenic carcinoma (synchronous primary tumours),
metastatic disease Infection Bacterial (Staphylococcus aureus, Klebsiella pneumoniae,
Pseudomonas)Granulomatous (endemic fungi, mycobacterial, Nocardia)Parasitic (Paragonismus, Echinococcus)
Inflammatory Granulomatosis with polyangitisLangerhans cell histocytosis Rheumatoid arthritisSarcoidosis
Vascular Pulmonary embolism with infarctionPneumoconioses Berylliosis, Caplan syndrome, coal-worker’s lung, silicosis Developmental Congenital pulmonary airway malformation, pulmonary
sequestration Drugs Amiodarone, infliximab, bleomycin, carbamazepine, othersOther Amyloidosis
-
Rozenberg and Shapera
Can Respir J Vol 21 No 3 May/June 2014e54
A few case reports have described pulmonary function tests inCaplan syndrome,which typicallyhave shownmild airwayobstruc-tion(7,12).Inthelargeststudytodate,however,Constantinidisetal(13)retrospectivelycompared24patientswithCaplansyndromeand36patientswithPMFsuggestingoverlapinpulmonaryfunctiontests.Whenadjustedforage,smokingandminingexposure,patientswithCaplansyndromehadlessairflowobstructionthanpatientswithPMF,butno other differenceswith respect to lung volumes anddiffusioncapacitywereidentified.Inthepresentcase,wespeculatethereducedVC and DLCO could be due to the patient’s upper lobe cavitaryfibroticchangesproducingaphysiologicalpatternoflungrestrictionthat resemblesmild PMF.Therewere no signs of diffuse interstitiallungdisease, pulmonaryvasculardiseaseorhistoryofdiaphragmaticdysfunction.
TherehavebeentwopathologiesdescribedinCaplansyndrome,bothillustratedinourcase.Theclassicpatterninitiallydescribedin1955hasanareaofcentralnecrosisoftheRAnodulessurroundedbydustparticles.Thisarea is furthersurroundedbymultiple inflamma-torycells:neutrophils,macrophagesandseveralgiantcells(Figure2A)(14).Thesecondpatternisthesilicotictype,inwhichthenodulesaresmallerandcontainthesamefeaturesofasilicoticnodule,butmain-tainanouterringofinflammatorycellsthatisdifferentfromasimplesilicotic nodule (Figure 2B) (10). The differential for these patho-logicalfindingsincludesRAnodules,silicoticnodulesandcoalwork-er’spneumoconiosis(7).
Despite numerous descriptions of the clinical features ofCaplansyndrome, thepathogenesisanddetailedunderstandingof the inter-actionsbetweeninhaledinorganicdustsandtheimmuneresponseinpatientswithRAhavenotbeendefined.Thereisincreasingevidencethatsilicainhalationcanbeassociatedwiththedevelopmentofauto-immune diseases such as RA, systemic sclerosis, systemic lupus ery-thematosusandantineutrophilcytoplasmicantibodyvasculitisbutitspathogenesisrequiresfurtherstudy(7).
ThepulmonarymanifestationsofCaplansyndromedonotrequireanyspecifictherapyunlessrarecomplicationsdevelopsuchasinfec-tionorbronchopleuralfistula(15).Inafewcases,theuseofcortico-steroids has been described in slowing the progression of rapidly
growingnodules(16).TheroleoftumournecrosisfactorinhibitorsinthetreatmentofCaplansyndromeisunknown,butworseningofRAnodules has been reported with tumour necrosis factor use (17).Treatmentshouldbefocusedonsmokingcessation, limitingoccupa-tionalexposureandcontrollingtheextrapulmonarymanifestationsoftheunderlyingRA.
SuMMAryThepresentcasedemonstratestheclassichistorical,radiologicalandpathologicalfeaturesofCaplansyndrome,arareentity.Thecaseout-linestheimportanceofconsideringabroaddifferentialinthemanage-mentofcavitarypulmonarynodules,especiallyinpatientswithRA.Given there is no specific therapy for Caplan syndrome, the focusshouldbeonmanagementofextrapulmonaryRA.
Post-test:• What is the classic clinical and radiological presentation of
Caplansyndrome?Caplan syndrome can present in patients with RA and occupa-tionaldustexposure(usuallycoal)withminimalrespiratorysymp-toms.Radiologydemonstrateswell-definedroundedopacitiesthatare 0.5 cm to 5 cm in size that are bilateral and predominantlyperipheral,andcancavitateandfluctuateovertheyears.• Whatisthedifferentialdiagnosisofcavitarypulmonarynodules
inRA?It is important to consider a broaddifferential in thework-upofcavitarypulmonarynodules(seeTable1)ensuringthatmalignancyandtuberculosisareexcluded.• HowdoyoutreatCaplansyndrome?Caplan syndromedoesnot require any particular treatment.Themanagement should be focused on treating the extrapulmonarymanifestationsofRA.
DiSCLoSurES:Theauthorshavenofinancialdisclosuresorconflictsofinteresttodeclare.
rEFErENCES1.CanadianArthiritisSociety,2013(AccessedMarch12,2014).
2.TanoueLT.Pulmonarymanifestationsofrheumatoidarthritis.ClinChestMed1998;19:667-685,viii.
3.ShannonTM,GaleME.Noncardiacmanifestationsofrheumatoiddiseaseinthethorax.JThoracImaging1992;7:19-29.
4.PattersonCD,HarvilleWE,PierceJA.Rheumatoidlungdisease.AnnInternMed1965;62:685-97.
5.HorlerAR,ThompsonM.Thepleuralandpulmonarycomplicationsofrheumatoidarthritis.AnnInternMed1959;51:1179-203.
6.YousemSA,ColbyTV,CarringtonCB.Lungbiopsyinrheumatoidarthritis.AmRevRespirDis1985;131:770-7.
7.SchreiberJ,KoschelD,KekowJ,etal.Rheumatoidpneumoconiosis(Caplan’ssyndrome).EurJInternMed2010;21:168-72.
8.CaplanA.Certainunusualradiologicalappearancesinthechestofcoal-minerssufferingfromrheumatoidarthritis.Thorax1953;8:29-37.
9.MorganWK.Rheumatoidpneumoconiosisinassociationwithasbestosis.Thorax1964;19:433-5.
10. CaplanA,CowenED,GoughJ.Rheumatoidpneumoconiosisinafoundryworker.Thorax1958;13:181-4.
11. ArakawaH,HonmaK,ShidaH,etal.ComputedtomographyfindingsofCaplansyndrome.JComputAssistTomogr2003;27:758-60.
12. DeCapitaniEM,SchwellerM,SilvaCM,etal.Rheumatoidpneumoconiosis(Caplan’ssyndrome)withaclassicalpresentation.JBrasPneumol2009;35:942-6.
13. ConstantinidisK,MuskAW,JenkinsJP,etal.PulmonaryfunctionincoalworkerswithCaplan’ssyndromeandnon-rheumatoidcomplicatedpneumosoniosis.Thorax1978;33:764-8.
14. GoughJ,RiversD,SealRM.Pathologicalstudiesofmodifiedpneumoconiosisincoal-minerswithrheumatoidarthritis:Caplan’ssyndrome.Thorax1955;10:9-18
15. HelmersR,GalvinJ,HunninghakeGW.Pulmonarymanifestationsassociatedwithrheumatoidarthritis.Chest1991;100:235-8.
16. DaviesD.Treatmentofrapidlyprogressiverheumatoidpneumoconiosis.BrJIndMed1973;30:396-401.
17. KekowJ,WelteT,KellnerU,etal.Developmentofrheumatoidnodulesduringanti-tumornecrosisfactoralphatherapywithetanercept.ArthritisRheum2002;46:843-4.